Ion-Selective analyzers consist of ion-selective electrodes that detect some specific ions in the presence of other ions and ion concentrations in an analytical solution, typically whole blood, plasma and serum. Ion-selective analysis also includes measurement of ion-concentrations of the detected specific ions and gases present in sample solution using certain probes, most commonly pH probe. Generally, metal ions such as the bromide, fluoride, cupric ions and cadmium, and dissolved gases like carbon dioxide, ammonia, nitrogen oxide, and oxygen are measured by using this technique.

View Report-

https://www.transparencymarketresearch.com/ion-selective-clinical-lab-analyzers.html

Ion-selective analyzers have the ability to retain the analysis data in the memory of analysis instrument and also provide calibration curves. Such ion-selective analyzers are designed to simultaneously measure electrolyte concentrations of ionized calcium, potassium, chloride, ionized magnesium, sodium and pH

Currently, North America and Europe account for more than fifty percent of the global ion-selective clinical lab analyzers market due to high prevalence and early introduction of advanced testing procedures. Emerging economies of Asia-Pacific, Latin America, and the Middle East are expected to project fastest growth in this market for the forecast period owing to rapid adoption of such clinical laboratory tests in these regions.

Some of the major factors driving the global ion-selective clinical lab analyzers market include rapid initiation of appropriate treatment in emergency cases, improved clinical and economical benefits received by the patients and the increased demand for analysis of selective ions with the patients on fluid therapy or in intensive care unit. However cost remains the primary issue restraining the ion-selective clinical lab analyzers market across developing nations.

Request Brochure-

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1636

Some of the key players contributing to the global market for ion-selective clinical lab analyzers include Abbott Point of Care, Microelectrodes, Inc., Alfa Wassermann, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Van London-pHoenix Company, and Thermo Fisher Scientific, Inc.